Lv41
440 积分 2023-08-15 加入
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
4小时前
待确认
Intergenerational Transmission of Diet‐Induced Obesity, Metabolic Imbalance, and Osteoarthritis in Mice
4个月前
已完结
Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment
6个月前
已完结
Eculizumab treatment for myasthenia gravis subgroups: 2021 update
6个月前
已完结
Ocular myasthenia gravis: a review and practical guide for clinicians
6个月前
已完结
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
6个月前
已完结
Update on Ocular Myasthenia Gravis
6个月前
已完结
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
6个月前
已完结
Injection site reactions with the use of biological agents
7个月前
已完结
皖公网安备34019202002308
